Drug details

Adlyxin (lixisenatide injection)

type of Antidiabetics, Glucagon-like Peptide-1 Agonists

Adlyxin (lixisenatide) Injection, for subcutaneous use acts as a GLP-1 receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• nausea,
• itching,
• vomiting,
• dizziness,
• headache,
• sweating,
• trouble swallowing,
• little or no urination,
• painful or difficult urination,
• swelling in your feet or ankles,
• irritability,
• fast heart rate,
• hunger,
• rapid heartbeats,
• shortness of breath
• severe pain in your upper stomach spreading to your back,
• tiredness, and
• shakiness,
• severe rash,
• anxious,

The following drugs are related to Adlyxin, either as a replacement or used together:

• Soliqua Injection (insulin glargine and lixisenatide)